Notably, this correlation suggests CCNE1’s involvement in modulating the tumor microenvironment, which could influence immune cell recruitment and activation, thus presenting potential therapeutic implications for enhancing cancer immunotherapy effectiveness. The gene discussed is CCNE1; the disease is cancer.